Absci (ABSI) Research & Development (2020 - 2026)

Absci has disclosed Research & Development across 7 years of filings, most recently posting $19.3 million for Q1 2026.

• Research & Development for Q1 2026 came in at $19.3 million, up 17.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $84.3 million (up 24.04% YoY), and the FY2025 annual result was $81.4 million, up 27.5% from the prior year.
• Research & Development came in at $19.3 million for Q1 2026 at Absci, down from $25.3 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $25.3 million in Q4 2025 to a low of $11.0 million in Q3 2023.
• The 5-year median for Research & Development is $15.8 million (2022), against an average of $16.0 million.
• Across the five-year window, Research & Development jumped 124.5% in 2022 and decreased 28.96% in 2023, its largest moves.
• Absci's Research & Development stood at $11.3 million in 2022, then gained by 8.43% to $12.3 million in 2023, then jumped by 49.78% to $18.4 million in 2024, then jumped by 37.93% to $25.3 million in 2025, then slipped by 23.96% to $19.3 million in 2026.
• The last three Research & Development figures came in at $19.3 million (Q1 2026), $25.3 million (Q4 2025), and $19.2 million (Q3 2025), per Business Quant data.